[Federal Register Volume 59, Number 134 (Thursday, July 14, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-17063]


[[Page Unknown]]

[Federal Register: July 14, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
[CDC-458]

 

Announcement of Cooperative Agreement to the World Health 
Organization

Summary

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 1994 funds for a sole source 
cooperative agreement with the World Health Organization (WHO) for 
Hantavirus Pulmonary Syndrome (HPS) research in epidemiology, 
pathogenesis and vaccine development. The activities are intended to 
strengthen the knowledge base of the epidemiology and pathogenesis of 
hantaviruses, improve diagnostics capabilities, and assist in the 
further development of a hantavirus vaccine. These programs will 
provide information for public policy and for targeting strategies for 
hantavirus-associated respiratory disease prevention and treatment 
programs. Approximately $60,000 is available in FY 1994 to fund one 
award. It is expected that the award will begin on or about September 
30, 1994, and will be made for a 12-month budget period within a 
project period of up to two years. Funding estimates may vary and are 
subject to change. A continuation award within an approved project 
period will be made on the basis of satisfactory progress and 
availability of funds.
    The purpose for this program is to assist research on hantaviruses 
that will help researchers in the U.S. to understand the epidemiology 
and mechanisms of immunity and immunopathology of hantavirus infection. 
It is also intended that the agreement assure that proper observations 
of vaccine trials are reliably made should further vaccine development 
be necessary in this country.

    The Public Health Service (PHS) is committed to achieving the 
health promotion and disease prevention objectives of Healthy People 
2000, a PHS-led national activity to reduce morbidity and mortality and 
improve the quality of life. This announcement is related to the 
priority area of Immunization and Infectious Diseases. (For ordering a 
copy of Healthy People 2000, see the Section Where to Obtain Additional 
Information.)

Authority

    This program is authorized under section 301(a) (42 U.S.C. 241(a)), 
311 (42 U.S.C. 243), and 317(k)(3)(42 U.S.C. 247b(k)(3)) of the Public 
Health Service Act, as amended, Pub. L. 95-626. Applicable program 
regulations are found in 42 CFR part 52, Grants for Research Projects.

Smoke-Free Workplace

    The Public Health Service strongly encourages all grant recipients 
to provide a smoke-free workplace and promote the non-use of all 
tobacco products. This is consistent with the PHS mission to protect 
and advance the physical and mental health of the American people.

Eligible Applicant

    Assistance will be provided only to the World Health Organization 
(WHO). No other applications are solicited. The program announcement 
and application kit have been sent to WHO.

    WHO is the coordinating agency for WHO Regional Offices including 
Pan American Health Organization (PAHO), European Regional Office 
(EURO), South East Asia Regional Office (SEARO), and Western Pacific 
Regional Office (WPRO) where assistance will be provided. WHO is the 
appropriate agency to establish collaboration among research groups to 
improve training, technology transfer and share comparative results.
    The CDC will collaborate in providing: Consultation, scientific and 
technical assistance and training for transfer of laboratory technology 
and logistics management for study of epidemiology of pathogenic 
hantaviruses in the Americas; scientific and technical assistance in 
the observation of the inactivated vaccine trials in both China and 
Russia; and training and on-site assistance in technical areas of 
expertise for investigating the mechanisms of immunity and 
immunopathology of hantavirus infection in Korea.

Executive Order 12372 Review

    This application is not subject to review under Executive Order 
12372, Intergovernmental Review of Federal Programs.

Public Health System Reporting Requirements

    This program is not subject to the Public Health System Reporting 
Requirements.

Catalog of Federal Domestic Assistance Number

    The Catalog of Federal Domestic Assistance Number for this program 
is 93.283.

Other Requirements

Human Subjects

    If the proposed project involves research on human subjects, the 
applicant must comply with the Department of Health and Human Services 
Regulations (45 CFR part 46) regarding the protection of human 
subjects. Assurance must be provided to demonstrate that the project 
will be subject to initial and continuing review by an appropriate 
institutional review committee. The applicant will be responsible for 
providing assurance in accordance with the appropriate guidelines and 
form provided in the application kit.

Where to Obtain Additional Information

    If you are interested in obtaining additional information on this 
program, please refer to Announcement Number 458 and contact Gordon R. 
Clapp, Grants Management Specialist, Grants Management Branch, 
Procurement and Grants Office, Centers for Disease Control and 
Prevention (CDC), 255 East Paces Ferry Road, NE., Room 314, Mailstop E-
18, Atlanta, GA 30305, telephone (404) 842-6508.
    A copy of Healthy People 2000 (Full Report: Stock No. 017-001-
00474-0) or Healthy People 2000 (Summary Report: Stock No. 017-001-
00473-1), referenced in the SUMMARY section, may be obtained through 
the Superintendent of Documents, Government Printing Office, 
Washington, DC 20402-9325, telephone (202) 783-3238.

    Dated: July 8, 1994.
Martha Katz,
Acting Associate Director for Management and Operations, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 94-17063 Filed 7-13-94; 8:45 am]
BILLING CODE 4163-18-P